Robert Putnak - Concepedia

Author

Robert Putnak

Walter Reed Army Institute of Research

Also Known As

R. J. Putnak, R. Putnak, ROBERT J. PUTNAK, ROBERT PUTNAK, Robert J Putnak, Robert J. Putnak, Robert Putnak

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research Armed Forces Research Institute of Medical Science Naval Medical Research Command United States Army Medical Research Institute of Infectious Diseases University of Maryland, Baltimore

About

Robert Putnak is an author at Walter Reed Army Institute of Research specializing in virology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.7K
2	Epidemiology	8	8	525
3	Natural Sciences	1	1	61
4	Allergy	1	1	18
5	Cell Biology	1	1	60

Robert Putnak

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial Katrin Ramsauer, Michael Schwameis, Christa Firbas, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyVaccine DevelopmentFirst-in-man Trial	2015	227
Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance Stephen J. Thomas, Ananda Nisalak, Kathryn B. Anderson, American Journal of Tropical Medicine and Hygiene	2009	222
Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain) K. Irie, Prem Mohan, Yasuyuki Sasaguri, Gene GeneticsSequence AnalysisNew Guinea-c StrainVirologyGenomics	1989	180
PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE Robert Edelman, Steven S. Wasserman, Sacared A Bodison, American Journal of Tropical Medicine and Hygiene VaccinationFormulations 1-15Vaccine DevelopmentNeurovirologyVaccine Target	2003	169
Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys Robert Putnak, Dave Barvir, Jeanne Burrous, The Journal of Infectious Diseases VaccinationVaccine DevelopmentRhesus MonkeysVaccine TargetImmunology	1996	166
West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy Alexander G. Pletnev, Robert Putnak, Jim Speicher, Proceedings of the National Academy of Sciences Viral ReplicationCleavage SiteViral PathogenesisImmunologyMolecular Biology	2002	125
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness Vicky Gunther, Robert Putnak, Kenneth H. Eckels, Vaccine Human Challenge ModelMedicineViral PathogenesisImmunologyAntiviral Response	2011	110
Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers Yvonne Van Gessel, Christoph Klade, Robert Putnak, Vaccine VaccinationAntibody TitersVaccine DevelopmentMedicineVaccine Target	2011	97
A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Stephen J. Thomas, Kenneth H. Eckels, Isabelle Carletti, American Journal of Tropical Medicine and Hygiene VaccinationVaccine SafetyImmunogenicity StudyVaccine DevelopmentMedicine	2012	95
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy Monika Simmons, Timothy Burgess, Julia Lynch, Virology VaccinationDengue VirusVaccine DevelopmentVaccine TargetImmunology	2009	94

Page 1